Effectiveness and safety of SARS‐CoV‐2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta‐analysis and meta‐regression-Reference-Cited by-同舟云学术

Effectiveness and safety of SARS‐CoV‐2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta‐analysis and meta‐regression

Published:2022-03-30 Issue:10 Volume:55 Page:1244-1264
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Bhurwal Abhishek¹^ORCID,Mutneja Hemant²^ORCID,Bansal Vikas³,Goel Akshay⁴,Arora Shilpa⁵,Attar Bashar²,Minacapelli Carlos D.¹,Kochhar Gursimran⁶^ORCID,Chen Lea Ann¹^ORCID,Brant Steve¹,Seril Darren¹

Affiliation:

1. Division of Gastroenterology and Hepatology Rutgers Robert Wood Johnson School of Medicine New Brunswick New Jersey USA

2. Division of Gastroenterology and Hepatology John H. Stroger Cook County Hospital Chicago Illinois USA

3. Division of Pulmonary and Critical Care Mayo Clinic Rochester New York USA

4. Division of Internal Medicine Westchester Medical Center Valhalla New York USA

5. Division of Rheumatology John H. Stroger Cook County Hospital Chicago Illinois USA

6. Division of Gastroenterology and Hepatology Allegheny Health Network Pittsburgh Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16913

Reference52 articles.

1. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

2. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

3. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

4. The four epidemiological stages in the global evolution of inflammatory bowel disease

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and the risk factors for the exacerbation of symptoms in patients with inflammatory bowel disease during the COVID-19 pandemic;Frontiers in Medicine;2024-06-05

2. Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis;Acta Dermato-Venereologica;2024-05-02

3. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses;Journal of Autoimmunity;2024-04

4. COVID-19 in patients with inflammatory bowel diseases: Characteristics and guidelines;Management, Body Systems, and Case Studies in COVID-19;2024

5. Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease;The Lancet Gastroenterology & Hepatology;2023-12